CAS 798544-25-9

Acetic acid, [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-,monohydrochloride

Description:

Acetic acid, [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, monohydrochloride, identified by CAS number 798544-25-9, is a chemical compound that features a complex structure incorporating both an acetic acid moiety and a piperazine derivative. This compound is characterized by its ability to form a hydrochloride salt, which enhances its solubility in aqueous environments, making it suitable for various applications in pharmaceutical formulations. The presence of the piperazine ring contributes to its potential biological activity, often associated with neuropharmacological effects. The chlorophenyl group may influence its lipophilicity and receptor binding properties, which are critical for its efficacy in medicinal chemistry. Additionally, the ethoxy group provides a hydrophobic character that can affect the compound's overall stability and interaction with biological membranes. Overall, this compound's unique structural features suggest potential utility in drug development, particularly in areas targeting central nervous system disorders.

Formula: C₂₁H₂₅ClN₂O₃ClH

2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid hydrochloride

CAS: 798544-25-9

Formula: C₂₁H₂₆Cl₂N₂O₃

Molecular weight: 425.3487

Ref: IN-DA01DOV8

2-[4-(4-Chloro-a-phenylbenzyl)-1-piperazinyl]-ethoxyacetic acid hydrochloride

CAS: 798544-25-9

2-[4-(4-Chloro-a-phenylbenzyl)-1-piperazinyl]-ethoxyacetic acid hydrochloride is a chemical compound that has been used to investigate the possible neuroprotective effects of cetirizine, an antihistamine. This drug was developed as a prodrug of cetirizine, which is converted in vivo to its active form. The main mechanism of action for this drug is inhibition of histamine release from mast cells and basophils by blocking H1 receptors. 2-[4-(4-Chloro-a-phenylbenzyl)-1-piperazinyl]-ethoxyacetic acid hydrochloride has also been shown to have beneficial effects on allergic symptoms and bowel disease in experimental models and clinical properties.

Formula: C₂₁H₂₅ClN₂O₃·HCl

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 425.35 g/mol

Ref: 3D-FC33467